GREAT POINT PARTNERS LLC

GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$380.9M2026 Q3+ $37.5M options (notional, not included)
Positions45
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.49.5%

GREAT POINT PARTNERS LLC reported 45 positions worth $380.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: IBRX (6.8%). Biggest move: exit ABVX ($53.3M).

10 / 45 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 IBRXPutImmunityBio$28.3M notional6.77%3,000,800———
▸ 2 VERAVera Therapeutics$26.1M6.24%808,717——-13.0%
▸ 3 VORVor Biopharma$21.5M5.14%1,126,910——-0.6%
▸ 4 AMLXAmylyx Pharmaceuticals$20.4M4.87%700,000——-4.5%
▸ 5 SGMTSagimet Biosciences$19.4M4.63%1,961,701——+3.4%
▸ 6 DFTXDefinium Therapeutics$19.4M4.63%508,735——-20.8%
▸ 7 IONSIonis Pharmaceuticals$18.8M4.48%420,000——-37.3%
▸ 8 GMABGenmab A/S$18.7M4.48%525,000———
▸ 9 SLGLSol-Gel Technologies$17.8M4.25%239,159——-25.8%
▸ 10 ZURAZura Bio$17.0M4.05%4,077,256———

Pro Feature

The remaining 35 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does GREAT POINT PARTNERS LLC hold as of Q3 2026?

GREAT POINT PARTNERS LLC reported 45 positions worth $380.9M in its Q3 2026 13F filing. Largest positions: IBRX (6.8%), VERA (6.2%), VOR (5.1%), AMLX (4.9%) and SGMT (4.6%).

What did GREAT POINT PARTNERS LLC buy in Q3 2026?

New positions: IONS, GMAB, BLTE, ABCL and CMPS (12 in all). Added to: VERA, LBRX, DFTX and DBVT.

What did GREAT POINT PARTNERS LLC sell in Q3 2026?

Reduced: ORKA, VOR, CTNM, IRD and ABVX (11 in all). Sold out entirely: ABVX, ALMS, RARE, IMMX and SLN (9 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.